370 related articles for article (PubMed ID: 12699766)
1. Differential psychostimulant-induced activation of neural circuits in dopamine transporter knockout and wild type mice.
Trinh JV; Nehrenberg DL; Jacobsen JP; Caron MG; Wetsel WC
Neuroscience; 2003; 118(2):297-310. PubMed ID: 12699766
[TBL] [Abstract][Full Text] [Related]
2. Dopamine transporter-dependent induction of C-Fos in HEK cells.
Yatin SM; Miller GM; Norton C; Madras BK
Synapse; 2002 Jul; 45(1):52-65. PubMed ID: 12112414
[TBL] [Abstract][Full Text] [Related]
3. Behavioral and biochemical responses to d-amphetamine in MCH1 receptor knockout mice.
Smith DG; Qi H; Svenningsson P; Wade M; Davis RJ; Gehlert DR; Nomikos GG
Synapse; 2008 Feb; 62(2):128-36. PubMed ID: 18000809
[TBL] [Abstract][Full Text] [Related]
4. Differences between electrically-, ritalin- and D-amphetamine-stimulated release of [3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of Attention-Deficit Hyperactivity Disorder.
Russell V; de Villiers A; Sagvolden T; Lamm M; Taljaard J
Behav Brain Res; 1998 Jul; 94(1):163-71. PubMed ID: 9708847
[TBL] [Abstract][Full Text] [Related]
5. Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene.
Carboni E; Spielewoy C; Vacca C; Nosten-Bertrand M; Giros B; Di Chiara G
J Neurosci; 2001 May; 21(9):RC141: 1-4. PubMed ID: 11312315
[TBL] [Abstract][Full Text] [Related]
6. Chronic food restriction increases fos-like immunoreactivity (FLI) induced in rat forebrain by intraventricular amphetamine.
Carr KD; Kutchukhidze N
Brain Res; 2000 Apr; 861(1):88-96. PubMed ID: 10751568
[TBL] [Abstract][Full Text] [Related]
7. The behavioral phenotype of pituitary adenylate-cyclase activating polypeptide-deficient mice in anxiety and depression tests is accompanied by blunted c-Fos expression in the bed nucleus of the stria terminalis, central projecting Edinger-Westphal nucleus, ventral lateral septum, and dorsal raphe nucleus.
Gaszner B; Kormos V; Kozicz T; Hashimoto H; Reglodi D; Helyes Z
Neuroscience; 2012 Jan; 202():283-99. PubMed ID: 22178610
[TBL] [Abstract][Full Text] [Related]
8. Long-term behavioral and neuronal cross-sensitization to amphetamine induced by repeated brief social defeat stress: Fos in the ventral tegmental area and amygdala.
Nikulina EM; Covington HE; Ganschow L; Hammer RP; Miczek KA
Neuroscience; 2004; 123(4):857-65. PubMed ID: 14751279
[TBL] [Abstract][Full Text] [Related]
9. Critical role of the embryonic mid-hindbrain organizer in the behavioral response to amphetamine and methylphenidate.
Tilleman H; Kofman O; Nashelsky L; Livneh U; Roz N; Sillaber I; Biegon A; Rehavi M; Brodski C
Neuroscience; 2009 Nov; 163(4):1012-23. PubMed ID: 19635527
[TBL] [Abstract][Full Text] [Related]
10. A triple mutation in the second transmembrane domain of mouse dopamine transporter markedly decreases sensitivity to cocaine and methylphenidate.
Chen R; Han DD; Gu HH
J Neurochem; 2005 Jul; 94(2):352-9. PubMed ID: 15998286
[TBL] [Abstract][Full Text] [Related]
11. Periadolescent mice show enhanced DeltaFosB upregulation in response to cocaine and amphetamine.
Ehrlich ME; Sommer J; Canas E; Unterwald EM
J Neurosci; 2002 Nov; 22(21):9155-9. PubMed ID: 12417638
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum.
Cenci MA; Kalén P; Mandel RJ; Wictorin K; Björklund A
Neuroscience; 1992; 46(4):943-57. PubMed ID: 1347413
[TBL] [Abstract][Full Text] [Related]
13. Conditioned place preference and locomotor activity in response to methylphenidate, amphetamine and cocaine in mice lacking dopamine D4 receptors.
Thanos PK; Bermeo C; Rubinstein M; Suchland KL; Wang GJ; Grandy DK; Volkow ND
J Psychopharmacol; 2010 Jun; 24(6):897-904. PubMed ID: 19282420
[TBL] [Abstract][Full Text] [Related]
14. Amphetamine-induced Fos is reduced in limbic cortical regions but not in the caudate or accumbens in a genetic model of NMDA receptor hypofunction.
Miyamoto S; Snouwaert JN; Koller BH; Moy SS; Lieberman JA; Duncan GE
Neuropsychopharmacology; 2004 Dec; 29(12):2180-8. PubMed ID: 15467708
[TBL] [Abstract][Full Text] [Related]
15. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
[TBL] [Abstract][Full Text] [Related]
16. Activation of afferents to the ventral tegmental area in response to acute amphetamine: a double-labelling study.
Colussi-Mas J; Geisler S; Zimmer L; Zahm DS; Bérod A
Eur J Neurosci; 2007 Aug; 26(4):1011-25. PubMed ID: 17714194
[TBL] [Abstract][Full Text] [Related]
17. Modulation of morphine-induced Fos-immunoreactivity by the cannabinoid receptor antagonist SR 141716.
Singh ME; Verty AN; Price I; McGregor IS; Mallet PE
Neuropharmacology; 2004 Dec; 47(8):1157-69. PubMed ID: 15567425
[TBL] [Abstract][Full Text] [Related]
18. Dissociations between cognitive and motor effects of psychostimulants and atomoxetine in hyperactive DAT-KO mice.
Del'Guidice T; Lemasson M; Etiévant A; Manta S; Magno LA; Escoffier G; Roman FS; Beaulieu JM
Psychopharmacology (Berl); 2014 Jan; 231(1):109-22. PubMed ID: 23912772
[TBL] [Abstract][Full Text] [Related]
19. Maternal behaviour in lactating rats stimulates c-fos in glutamate decarboxylase-synthesizing neurons of the medial preoptic area, ventral bed nucleus of the stria terminalis, and ventrocaudal periaqueductal gray.
Lonstein JS; De Vries GJ
Neuroscience; 2000; 100(3):557-68. PubMed ID: 11098119
[TBL] [Abstract][Full Text] [Related]
20. Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons.
Canseco-Alba A; Schanz N; Sanabria B; Zhao J; Lin Z; Liu QR; Onaivi ES
Behav Brain Res; 2019 Mar; 360():286-297. PubMed ID: 30508607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
